Luda Diatchenko, MD, PhD is a Canada Research Chair in Human Pain Genetics, Fellow of the Royal Society of Canada, and a Professor at the Faculty of Dentistry and Medicine, at McGill University. Dr. Diatchenko earned her MD and PhD in the field of Molecular Biology from the Russian State Medical University.
Dr. Diatchenko started her career in industry, she was a Leader of the RNA Expression Group at Clontech, Inc., and subsequently, Director of Gene Discovery at Attagene, Inc. Dr. Diatchenko’s academic career started in 2000 in the Center for Neurosensory Disorders at the University of North Carolina.
Her research since then is focused on determining the genetic mechanisms that impact and shape human pain perception and risk of development of chronic pain conditions, enabling new approaches to identify drug targets, treatment responses to analgesics, and diagnostics.
